Docusign Envelope ID: E15EFA22-E331-4851-8A60-18923E12A759
Registered number: 3893522 Charity number: 1154725
THE BRITISH NEUROPSYCHIATRY ASSOCIATION
(A Company Limited by Guarantee)
UNAUDITED
TRUSTEES' REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2025
Docusign Envelope ID: E15EFA22-E331-4851-8A60-18923E12A759
THE BRITISH NEUROPSYCHIATRY ASSOCIATION (A Company Limited by Guarantee)
| CONTENTS | |
|---|---|
| Page | |
| Reference and administrative details of the company, its trustees and advisers | 1 |
| Trustees' Report | 2 - 6 |
| Independent Examiner's Report | 7 - 8 |
| Statement of Financial Activities | 9 |
| Balance Sheet | 10 |
| Notes to the Financial Statements | 11 - 19 |
Docusign Envelope ID: E15EFA22-E331-4851-8A60-18923E12A759
THE BRITISH NEUROPSYCHIATRY ASSOCIATION (A Company Limited by Guarantee)
REFERENCE AND ADMINISTRATIVE DETAILS OF THE COMPANY, ITS TRUSTEES AND ADVISERS FOR THE YEAR ENDED 30 JUNE 2025
Trustees
V Bell, President (from March 2025) G Blackman, Treasurer (appointed 14 March 2025) B Ghosh, President (to February 2025) A Zeman, Ex-officio R Cole L Knowles S Garfinkel J Fish I Hoeritzauer (appointed 14 March 2025) S Komati (appointed 14 March 2025) L Li (appointed 14 March 2025) M Wise (appointed 14 March 2025) J Isaacs (resigned 14 March 2025)
L McWhirter (resigned 14 March 2025)
T Nicholson, Co-opted for the Faculty of Neuropsychiatry, Royal College of Psychiatrists (resgined 14 March 2025)
Company registered number
3893522
Charity registered number
1154725
Registered office
21-27 Lamb's Conduit Street London WC1N 3GS
Accountants
Griffin Stone Moscrop & Co Chartered Accountants 21-27 Lamb's Conduit Street London WC1N 3GS
Bankers
Barclays Bank plc Leicester LE87 2BB
Page 1
Docusign Envelope ID: E15EFA22-E331-4851-8A60-18923E12A759
THE BRITISH NEUROPSYCHIATRY ASSOCIATION (A Company Limited by Guarantee)
TRUSTEES' REPORT FOR THE YEAR ENDED 30 JUNE 2025
The trustees (who are also directors of the charity for the purposes of company law) present their report together with the financial statements of the company for the year ended 30 June 2025.
The annual report serves the purposes of both a trustees' report and a directors' report under company law. The trustees confirm that the annual report and financial statements of the charitable company comply with the current statutory requirements, the requirements of the charitable company's governing document and the provisions of the Statement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) (effective 1 January 2019).
Since the company qualifies as small under section 382 of the Companies Act 2006, the Strategic Report required of medium and large companies under the Companies Act 2006 (Strategic Report and Directors' Report) Regulations 2013 has been omitted.
The company is also known as the BNPA.
Objectives and activities
a. Policies and objectives
The object of the charitable company is the advancement of health for the public benefit by bringing about improved health care for people with neuropsychiatric disorders in particular by increasing, integrating and disseminating knowledge and understanding of the relationships between brain function and human behaviour through open learned meetings.
In setting objectives and planning for activities, the trustees have given due consideration to general guidance published by the Charity Commission relating to public benefit, including the guidance 'Public benefit: running a charity (PB2)'.
b. Activities for achieving objectives
In furthering its object, the charitable company:
-
provides a multidisciplinary, inclusive forum for the dissemination of research findings and best practices in clinical care across a variety of professional groups;
-
encourages and facilitates cross-disciplinary discussion of clinical and academic issues across the related fields of psychiatry, neurology and neuropsychology;
-
runs high-quality scientific meetings and educational courses, including collaboration with other relevant societies; and
-
promotes the public understanding of neuropsychiatry within the United Kingdom and internationally.
The charitable company's policy is to give priority to activities that will meet greatest needs, subject to the existence of opportunity to act. The charitable company sets and continuously revises its aims accordingly.
Page 2
Docusign Envelope ID: E15EFA22-E331-4851-8A60-18923E12A759
THE BRITISH NEUROPSYCHIATRY ASSOCIATION (A Company Limited by Guarantee)
TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 JUNE 2025
Structure, governance and management
a. Constitution
The British Neuropsychiatry Association is registered as a company limited by guarantee (number 3893522) and was set up by a Memorandum of Association dated 3 September 1999. The company was incorporated on 1 December 1999 and became a registered charity (number 1154725) on 25 November 2013.
b. Methods of appointment or election of trustees
The management of the charitable company is the responsibility of the trustees who are elected under the terms of the Memorandum of Association.
Trustees are selected for their professional knowledge and experience in the fields of psychiatry, neurology and neuropsychology, in which the charitable company operates. They are likely already to be familiar with the charitable company's purposes and activities.
Newly appointed Trustees receive advice, as an induction, on the history, objectives and activities of the charitable company, on Trustee responsibilities (in particular through provision of the Charity Commission publication The Essential Trustee: An Introduction ) and on the charitable company's financial situation.
c. Organisational structure and decision making
The charitable company is governed by its board of trustees (which is also the board of directors).
The board of trustees is responsible for all decisions with regard to the charitable company's priorities amongst its aims, activities and use of resources.
d. Risk management
The trustees have assessed the major risks to which the charitable company is exposed, in particular those related to the operations and finances of the charitable company, and are satisfied that systems and procedures are in place to mitigate exposure to those risks.
Page 3
Docusign Envelope ID: E15EFA22-E331-4851-8A60-18923E12A759
THE BRITISH NEUROPSYCHIATRY ASSOCIATION (A Company Limited by Guarantee)
TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 JUNE 2025
Achievements and performance
a. Review of activities
The BNPA remains dedicated to fostering collaboration and advancing knowledge at the neuroscience psychiatry interface. At events such as the 2024 December Teaching Weekend and the 2025 Annual Conference, attendees experienced a rich array of activities, presentations, and discussions, showcasing innovative developments in the field.
The British Neuropsychiatry Association’s Oxford Teaching Weekend is an immersive, in-person course focused on the core principles of neuropsychiatry. Based at St Anne’s College, the weekend combines expert-led teaching with a relaxed, collegiate learning environment. The course is designed for trainees and professionals in neurology, psychiatry, neuropsychology, is fully residential also offers strong networking opportunities, fostering cross-specialty connections and peer learning.
The 38th Annual Conference of the British Neuropsychiatry Association took place on 13–14 March 2025. It was held at Duchess Mews, London, UK, bringing together clinicians, researchers, psychologists, and other professionals working at the interface of neurology, psychiatry and cognition.
Key topics included impulsivity, functional neurological disorders (FND), sleep and neuropsychiatry, traumatic brain injury, and aspects of human cognition and experience such as imagination and “felt presence”. Speakers included leading figures such as Professor Hugh Garavan, Professor James Rowe, Professor Alan Carson (BNPA Medal Lecture), Professor Guy Leschziner, Professor Adam Zeman, and Professor Benjamin AldersonDay, alongside lived-experience contributors and early-career researchers presenting original work.
The conference attracted 217 delegates in-person and 64 joined on-line, over the two days fostering valuable networking opportunities and intellectual exchange.
Additionally, throughout the year, BNPA maintained communication with members through email updates, newsletters, and social media, ensuring ongoing engagement and dissemination of relevant information.
b. Investment policy and performance
The charitable company has adopted a highly risk-averse investment policy. Funds not expected to be called upon in the short-term are placed on deposit in a United Kingdom bank at the best terms available.
c. Investment policy and performance
The charitable company has adopted a highly risk-averse investment policy. Funds not expected to be called upon in the short-term are placed on deposit in a United Kingdom bank at the best terms available.
Financial review
a. Going concern
After making appropriate enquiries, the trustees have a reasonable expectation that the charitable company has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements.
Page 4
Docusign Envelope ID: E15EFA22-E331-4851-8A60-18923E12A759
THE BRITISH NEUROPSYCHIATRY ASSOCIATION (A Company Limited by Guarantee)
TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 JUNE 2025
b. Reserves policy
It is the policy of the charitable company to hold in reserve a sufficient amount to be able to undertake its planned activities should its income stream fail significantly, and subsequently enable an orderly close-down of the charitable company should it become unable to continue.
c. Principal risks and uncertainties
There are few risks and uncertainties that can impact on the performance of the Association. The BNPA board closely monitor possible risks on an on-going basis with quarterly meetings where at least four executive directors are present.
Financial risk
Sponsorship and support from industry should not be relied upon and the board will limit the risk of financial losses by aiming to break even in the Association's main activities, the annual conference and the teaching weekend, and not rely on outside support. While the board will still encourage industry support it will not rely on this as a main source of financing the activities, also recognising the needs and wishes of their members with regards to good governance.
The board will ensure the continuing process of promoting the Association through its current members and the appropriate institutions and societies, therefore encouraging new members to join the Association to ensure a steady growth in membership numbers or at least maintain a good level of member numbers to guarantee an annual income through subscription payments to support the administration of the Association.
The board recognises the cost implications of inviting overseas speakers to its annual meeting and therefore will limit the number of overseas speakers invited each year, at the same time recognising the interest of overseas speakers to the Associations membership and the potential draw that overseas speakers have on delegates attending the meetings.
d. Financial activities and affairs
The statement of financial activities for the year ended 30 June 2025 shows total income of £114,709 and net surplus of £7,990.
In the opinion of the trustees, the overall state of affairs of the charitable company at 30 June 2025 is satisfactory.
e. Plans for future periods
The BNPA 2024 December Teaching Weekend and 2025 Annual Conference exemplified the organisation's commitment to excellence in education, research, and clinical practice within the realm of neuropsychiatry.
These events not only disseminated knowledge but also cultivated a vibrant community of professionals dedicated to unravelling the complexities of the brain-mind interface. As we look forward to future endeavours, the legacy of collaboration and innovation fostered by the BNPA continues to inspire and propel the field of neuropsychiatry towards new horizons.
Page 5
Docusign Envelope ID: E15EFA22-E331-4851-8A60-18923E12A759
THE BRITISH NEUROPSYCHIATRY ASSOCIATION (A Company Limited by Guarantee)
TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 JUNE 2025
Members' liability
IIn the event of the charitable company being wound up, the members guarantee to contribute an amount not exceeding £10 to the charitable company's assets. During 2024 there were 480 members of the charitable company, all of which were individuals.
Statement of trustees' responsibilities
The trustees (who are also the directors of the company for the purposes of company law) are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
Company law requires the trustees to prepare financial statements for each financial . Under company law, the trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of its incoming resources and application of resources, including its income and expenditure, for that period. In preparing these financial statements, the trustees are required to:
-
select suitable accounting policies and then apply them consistently;
-
observe the methods and principles of the Charities SORP (FRS 102);
-
make judgements and accounting estimates that are reasonable and prudent;
-
state whether applicable UK Accounting Standards (FRS 102) have been followed, subject to any material departures disclosed and explained in the financial statements;
-
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Approved by order of the members of the board of trustees on 2 March 2026 and signed on their behalf by:
................................................
G Blackman Treasurer
Page 6
Docusign Envelope ID: E15EFA22-E331-4851-8A60-18923E12A759
THE BRITISH NEUROPSYCHIATRY ASSOCIATION (A Company Limited by Guarantee)
INDEPENDENT EXAMINER'S REPORT FOR THE YEAR ENDED 30 JUNE 2025
Independent Examiner's Report to the Trustees of The British Neuropsychiatry Association ('the company')
I report to the charity trustees on my examination of the financial statements of the company for the year ended 30 June 2025.
Responsibilities and Basis of Report
As the trustees of the company (and its directors for the purposes of company law) you are responsible for the preparation of the financial statements in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').
Having satisfied myself that the financial statements of the company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of the company's financial statements carried out under section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.
Independent Examiner's Statement
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:
-
accounting records were not kept in respect of the company as required by section 386 of the 2006 Act; or
-
the financial statements do not accord with those records; or
-
the financial statements do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the financial statements give a 'true and fair' view which is not a matter considered as part of an independent examination; or
-
the financial statements have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102).
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached.
Page 7
Docusign Envelope ID: E15EFA22-E331-4851-8A60-18923E12A759
THE BRITISH NEUROPSYCHIATRY ASSOCIATION (A Company Limited by Guarantee)
INDEPENDENT EXAMINER'S REPORT (CONTINUED) FOR THE YEAR ENDED 30 JUNE 2025
This report is made solely to the charity trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. My work has been undertaken so that I might state to the charity trustees those matters I am required to state to them in an Independent Examiner's Report and for no other purpose. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than the company and the charity trustees as a body, for my work or for this report.
Signed:
Dated: 2 March 2026
Reema Mistry FCA
Griffin Stone Moscrop & Co Chartered Accountants 21-27 Lamb's Conduit Street London WC1N 3GS
Page 8
Docusign Envelope ID: E15EFA22-E331-4851-8A60-18923E12A759
THE BRITISH NEUROPSYCHIATRY ASSOCIATION
(A Company Limited by Guarantee)
STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 30 JUNE 2025
| Note Income from: Grants, donations and similar income 4 Charitable activities 5 Investments 6 Other income Total income Expenditure on: Charitable activities 7 Total expenditure Net income/(expenditure) Net movement in funds Reconciliation of funds: Total funds brought forward Net movement in funds Total funds carried forward |
Unrestricted fund 2025 £ 1,750 112,959 - - 114,709 106,719 106,719 7,990 7,990 55,320 7,990 63,310 |
Total funds 2025 £ 1,750 112,959 - - 114,709 106,719 106,719 7,990 7,990 55,320 7,990 63,310 |
Total funds 2024 £ - 114,566 45 410 115,021 118,871 118,871 (3,850) (3,850) 59,170 (3,850) 55,320 |
|---|---|---|---|
All of the above is in respect of the charitable company's unrestricted general fund. The charitable company does not have any designated, restricted or endowment funds.
The statement of financial activities includes all gains and losses recognised in the year.
The notes on pages 11 to 19 form part of these financial statements.
Page 9
Docusign Envelope ID: E15EFA22-E331-4851-8A60-18923E12A759
THE BRITISH NEUROPSYCHIATRY ASSOCIATION
(A Company Limited by Guarantee) REGISTERED NUMBER: 3893522
BALANCE SHEET AS AT 30 JUNE 2025
| Note Current assets Debtors 11 Cash at bank Current liabilities Creditors: amounts falling due within one year 12 Net current assets Total net assets Charity funds Unrestricted fund 14 Total funds |
2025 £ 328 79,656 79,984 (16,674) |
2025 £ 63,310 63,310 63,310 63,310 |
2024 £ 25,052 61,165 86,217 (30,897) |
2024 £ 55,320 |
|---|---|---|---|---|
| 55,320 | ||||
| 55,320 | ||||
| 55,320 |
The company was entitled to exemption from audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit for the year in question in accordance with section 476 of Companies Act 2006.
The trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and preparation of financial statements.
The financial statements have been prepared in accordance with the provisions applicable to entities subject to the small companies regime.
The financial statements were approved and authorised for issue by the trustees on 02 March 2026 and signed on their behalf by:
................................................
G Blackman Treasurer
The notes on pages 11 to 19 form part of these financial statements.
Page 10
Docusign Envelope ID: E15EFA22-E331-4851-8A60-18923E12A759
THE BRITISH NEUROPSYCHIATRY ASSOCIATION (A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2025
1. General information
The British Neuropsychiatry Association is a charitable company registered in England. Its registered office address is 21-27 Lamb's Conduit Street, London WC1N 3GS.
The British Neuropsychiatry Association is a company limited by guarantee. In the event of the company being wound up, the liability in respect of the guarantee is limited to £10 per member of the company.
The financial statements are prepared in sterling, which is the functional currency of the company, and are rounded to the nearest £1.
2. Accounting policies
2.1 Basis of preparation of financial statements
The financial statements have been prepared in accordance with the Charities SORP (FRS 102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.
Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.
The preparation of financial statements in compliance with the Charities SORP (FRS 102) and FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgement in applying the charity's accounting policies (see note 3).
The British Neuropsychiatry Association meets the definition of a public benefit entity under FRS 102.
2.2 Going concern
There are no material uncertainties concerning the charitable company's ability to continue as a going concern.
2.3 Income
All income is recognised once the company has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.
Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation.
Page 11
Docusign Envelope ID: E15EFA22-E331-4851-8A60-18923E12A759
THE BRITISH NEUROPSYCHIATRY ASSOCIATION (A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2025
2. Accounting policies (continued)
2.4 Expenditure
Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably.
All expenditure is accounted for on an accruals basis. All expenses including support costs and governance costs, are allocated to the applicable expenditure headings.
Expenditure on charitable activities is incurred on directly undertaking the activities which further the company's objectives, as well as any associated support costs.
Expenditure on charitable activities is incurred on directly undertaking the activities which further the company's objectives, as well as any associated support costs.
All expenditure is inclusive of irrecoverable VAT.
2.5 Interest receivable
Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the company; this is normally upon notification of the interest paid or payable by the institution with whom the funds are deposited.
2.6 Taxation
The company is considered to pass the tests set out in Paragraph 1 Schedule 6 of the Finance Act 2010 and therefore it meets the definition of a charitable company for UK corporation tax purposes. Accordingly, the company is potentially exempt from taxation in respect of income or capital gains received within categories covered by Chapter 3 Part 11 of the Corporation Tax Act 2010 or Section 256 of the Taxation of Chargeable Gains Act 1992, to the extent that such income or gains are applied exclusively to charitable purposes.
The company is not, however, exempt from value added tax. Irrecoverable value added tax is included in the cost of those items to which it relates.
2.7 Debtors
Trade and other debtors are recognised at the settlement amount after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.
2.8 Cash at bank
Cash at bank includes short-term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.
Page 12
Docusign Envelope ID: E15EFA22-E331-4851-8A60-18923E12A759
THE BRITISH NEUROPSYCHIATRY ASSOCIATION (A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2025
2. Accounting policies (continued)
2.9 Liabilities and provisions
Liabilities are recognised when there is an obligation at the Balance Sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably.
Liabilities are recognised at the amount that the company anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services it must provide.
Provisions are measured at the best estimate of the amounts required to settle the obligation. Where the effect of the time value of money is material, the provision is based on the present value of those amounts, discounted at the pre-tax discount rate that reflects the risks specific to the liability. The unwinding of the discount is recognised in the Statement of Financial Activities as a finance cost.
2.10 Financial instruments
The company only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.
2.11 Fund accounting
General funds are unrestricted funds which are available for use at the discretion of the trustees in furtherance of the general objectives of the company and which have not been designated for other purposes.
Investment income, gains and losses are allocated to the appropriate fund.
3. Judgements in applying accounting policies and key sources of estimation uncertainty
In the application of the charitable company's accounting policies, the trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised, if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. However, there are no judgements or assumptions that have a significant risk of causing material adjustment.
Page 13
Docusign Envelope ID: E15EFA22-E331-4851-8A60-18923E12A759
THE BRITISH NEUROPSYCHIATRY ASSOCIATION (A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2025
4. Income from grants, donations and similar income
| Unrestricted | Total | Total | |
|---|---|---|---|
| fund | funds | funds | |
| 2025 | 2025 | 2024 | |
| £ | £ | £ | |
| Grants | 1,750 | 1,750 | - |
5. Income from charitable activities
| Unrestricted fund 2025 £ Membership subscriptions 22,675 Delegates fees 59,156 Teaching weekend 25,195 Gift Aid receivable on membership subscriptions 5,933 Total 2025 112,959 Total 2024 114,566 |
Total funds 2025 £ 22,675 59,156 25,195 5,933 112,959 114,566 |
Total funds 2024 £ 18,239 57,268 33,971 5,088 |
|---|---|---|
| 114,566 | ||
6. Investment income
| Unrestricted fund 2025 £ Bank interest receivable - Total 2024 45 |
Total funds 2025 £ - 45 |
Total funds 2024 £ 45 |
|---|---|---|
Page 14
Docusign Envelope ID: E15EFA22-E331-4851-8A60-18923E12A759
THE BRITISH NEUROPSYCHIATRY ASSOCIATION (A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2025
7. Analysis of expenditure on charitable activities
Summary by fund type
| Unrestricted funds 2025 £ Direct costs 106,719 Total 2025 106,719 Total 2024 118,871 |
Total 2025 £ 106,719 106,719 118,871 |
Total 2024 £ 118,871 |
|---|---|---|
| 118,871 | ||
8. Analysis of expenditure by activities
| Direct costs Total 2024 |
Activities undertaken directly 2025 £ 90,383 101,745 |
Support costs 2025 £ 16,336 17,126 |
Total funds 2025 £ 106,719 118,871 |
Total funds 2024 £ 118,871 |
|---|---|---|---|---|
Analysis of direct costs
| Cost of venues and other expenses Expenditure in respect of teaching weekend Speakers' expenses Administration and office expenses |
Total funds 2025 £ 51,869 30,871 6,592 1,051 90,383 |
Total funds 2024 £ 62,416 32,629 6,556 144 |
|---|---|---|
| 101,745 |
Page 15
Docusign Envelope ID: E15EFA22-E331-4851-8A60-18923E12A759
THE BRITISH NEUROPSYCHIATRY ASSOCIATION (A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2025
8. Analysis of expenditure by activities (continued)
Analysis of support costs
| Administration and office expenses Accountancy fees |
Total funds 2025 £ 14,065 2,271 16,336 |
Total funds 2024 £ 13,233 3,893 |
|---|---|---|
| 17,126 |
9.
Independent examiner's remuneration
| 2025 | 2024 | |
|---|---|---|
| £ | £ | |
| Independent examiner fees | 2,271 | 3,893 |
10. Trustees' remuneration and expenses
During the year, no trustees received any remuneration or other benefits (2024 - £NIL).
During the year ended 30 June 2025, £1,634 (2024 - £382) of expenses were reimbursed or paid directy to 6 trustees (2024 - 1 trustee). Where applicable, such expenses are included in the appropriate categories of expenditure.
11. Debtors
| Due within one year Trade debtors Prepayments |
2025 £ 328 - 328 |
2024 £ 5,216 19,836 |
|---|---|---|
| 25,052 |
Page 16
Docusign Envelope ID: E15EFA22-E331-4851-8A60-18923E12A759
THE BRITISH NEUROPSYCHIATRY ASSOCIATION
(A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2025
12. Creditors: amounts falling due within one year
| Trade creditors Accruals and deferred income Deferred income at 1 July 2024 Resources deferred during the year Amounts released from previous years Deferred income at 30 June 2025 |
2025 £ - 16,674 16,674 2025 £ 9,167 13,636 (9,167) 13,636 |
2024 £ 18,023 12,874 |
|---|---|---|
| 30,897 | ||
| 2024 £ 10,626 9,167 (10,626) |
||
| 9,167 |
Memberships run each year from 1 January to 31 December, so as at the balance sheet date 50% of membership subscriptions are deferred. These amounts are included within accruals and deferred income above.
13. Financial instruments
| 2025 | 2024 | |
|---|---|---|
| £ | £ | |
| Financial assets | ||
| Financial assets measured at fair value through income and expenditure | 79,656 | 61,165 |
Financial assets measured at fair value through income and expenditure comprises of cash at bank.
Page 17
Docusign Envelope ID: E15EFA22-E331-4851-8A60-18923E12A759
THE BRITISH NEUROPSYCHIATRY ASSOCIATION (A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2025
| 14. Statement of funds Statement of funds - current year Balance at 1 July 2024 £ Unrestricted fund General Fund 55,320 Statement of funds - prior year Balance at 1 July 2023 £ Unrestricted fund General Fund 59,170 15. Analysis of net assets between funds Analysis of net assets between funds - current year Current assets Creditors: amounts falling due within one year Total |
Income £ Expenditure £ 114,709 (106,719) Income £ Expenditure £ 115,021 (118,871) Unrestricted fund 2025 £ 79,984 (16,674) 63,310 |
Balance at 30 June 2025 £ 63,310 Balance at 30 June 2024 £ 55,320 Total funds 2025 £ 79,984 (16,674) 63,310 |
|---|---|---|
Page 18
Docusign Envelope ID: E15EFA22-E331-4851-8A60-18923E12A759
THE BRITISH NEUROPSYCHIATRY ASSOCIATION (A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2025
15. Analysis of net assets between funds (continued)
Analysis of net assets between funds - prior year
| Current assets Creditors: amounts falling due within one year Total |
Unrestricted fund 2024 £ 86,217 (30,897) 55,320 |
Total funds 2024 £ 86,217 (30,897) 55,320 |
|---|---|---|
Page 19